State of Wisconsin Investment Board’s CASI Pharmaceuticals CASI Stock Holding History

State of Wisconsin Investment Board’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,190	Closed	-$221K	–	2081
2021 Q1	$221K	Hold	9,190	–	–	﹤0.01%	1986
2020 Q4	$271K	Buy	+9,190	New	+$200K	﹤0.01%	1896
2020 Q1	–	Sell	-6,900	Closed	-$213K	–	1700
2019 Q4	$213K	Hold	6,900	–	–	﹤0.01%	1577
2019 Q3	$230K	Hold	6,900	–	–	﹤0.01%	1489
2019 Q2	$221K	Buy	6,900 +150	+2%	+$4.79K	﹤0.01%	1479
2019 Q1	$194K	Buy	6,750 +1,550	+30%	+$54K	﹤0.01%	1464
2018 Q4	$209K	Hold	5,200	–	–	﹤0.01%	1452
2018 Q3	$243K	Buy	+5,200	New	+$363K	﹤0.01%	1485

Other funds holding CASI

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

IACGFIA

IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State of Wisconsin Investment Board's CASI Position: Q2 2021 in Review

State of Wisconsin Investment Board sold out of CASI Pharmaceuticals (CASI) in Q2 2021, closing a stake of 9,190 shares — an estimated $221K sold.

State of Wisconsin Investment Board first reported a position in CASI in Q3 2018 and held it in 8 quarters. The position peaked at $271K in Q4 2020. 68 funds tracked by Wall St. Rank hold CASI as of Q2 2021.

State of Wisconsin Investment Board reported no remaining CASI Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
State of Wisconsin Investment Board sold 9,190 CASI Pharmaceuticals shares in Q2 2021, an estimated $221K.
State of Wisconsin Investment Board first reported a position in CASI Pharmaceuticals in Q3 2018 and held it in 8 quarters.
State of Wisconsin Investment Board's CASI Pharmaceuticals position peaked at $271K in Q4 2020.
68 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2021, filed 12 Aug 2021.